Jana Pospíšilová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jana Pospíšilová has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Petr Cankař
Department of Organic Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 1192/12, 77900 Olomouc, Czech Republic
3 shared publications - Ivan Nemec
Department of Inorganic Chemistry, Faculty of Science, Palacky University, 17. listopadu 12, 771 46 Olomouc, Czech Republic
2 shared publications - Adam Přibylka
Department of Organic Chemistry Faculty of Science Palacký University Olomouc Czech Republic
1 shared publication Adéla Srovnalová
Department of Organic Chemistry Faculty of Science Palacký University Olomouc Czech Republic
1 shared publicationAnna Chládková
Department of Organic Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 1192/12, 77900 Olomouc, Czech Republic
1 shared publication- Daniel Toman
Department of Organic Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 1192/12, 77900 Olomouc, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 12 November 2026
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 368 (22)
Axially Chiral Sulfonic Acids for Atroposelective Synthesis of C–N Axially Chiral 1,2‐Diarylbenzimidazoles
Axially chiral sulfonic acids are introduced as a new class of organocatalysts for atroposelective synthesis. Cyclization of structurally diverse o ‐phenylenediamines with aromatic and heteroaromatic aldehydes efficiently afforded 29 C–N axially chiral 1,2‐diarylbenzimidazoles in enantiomeric ratios of up to 16:84 using only 2.5 mol % catalyst. Investigation of substrate effects revealed that substituents located in the immediate vicinity of the developing C–N chiral axis play a key role in stereocontrol. The enantiomeric ratios were readily enhanced by simple recrystallization, exceeding 99:1 in several cases.
- 12 November 2026
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 368 (22)
Open AccessAxially Chiral Sulfonic Acids for Atroposelective Synthesis of C–N Axially Chiral 1,2‐Diarylbenzimidazoles
Axially chiral sulfonic acids are introduced as a new class of organocatalysts for atroposelective synthesis. Cyclization of structurally diverse o ‐phenylenediamines with aromatic and heteroaromatic aldehydes efficiently afforded 29 C–N axially chiral 1,2‐diarylbenzimidazoles in enantiomeric ratios of up to 16:84 using only 2.5 mol % catalyst. Investigation of substrate effects revealed that substituents located in the immediate vicinity of the developing C–N chiral axis play a key role in stereocontrol. The enantiomeric ratios were readily enhanced by simple recrystallization, exceeding 99:1 in several cases.
- Open Access
D-Hexopyranosides with Vicinal Nitrogen-Containing Functionalities
Various substituted D-hexopypyranosides units with nitrogen-containing functionalities are present in many important natural compounds and pharmaceutical substances. Since their complex structural diversity contributes to a broad spectrum of biological functions and activities, these derivatives are frequently studied. This review covers syntheses of D-hexopyranosides with vicinal nitrogen-containing functionalities since the 1960s, when the first articles emerged. The syntheses are arranged according to the positions of substitutions, to form a relative configuration of vicinal functionalities, and synthetic methodologies.
Open AccessD-Hexopyranosides with Vicinal Nitrogen-Containing Functionalities
Various substituted D-hexopypyranosides units with nitrogen-containing functionalities are present in many important natural compounds and pharmaceutical substances. Since their complex structural diversity contributes to a broad spectrum of biological functions and activities, these derivatives are frequently studied. This review covers syntheses of D-hexopyranosides with vicinal nitrogen-containing functionalities since the 1960s, when the first articles emerged. The syntheses are arranged according to the positions of substitutions, to form a relative configuration of vicinal functionalities, and synthetic methodologies.
- Open Access
- 8 July 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (34) , 6966-6980
Atropisomeric 1-phenylbenzimidazoles affecting microtubule organization: influence of axial chirality
Benzimidazoles are frequently used in medicinal chemistry. Their anticancer effect is among the most prominent biological activities exhibited by this scaffold. Although numerous benzimidazole derivatives have been synthesized, possible atropisomerism of ortho-substituted 1-phenylbenzimidazoles has been largely overlooked. The aim of this research was to synthesize a small library of novel atropisomeric benzimidazole derivatives and explore their biological activity in various cancer and normal human cell lines. The new unique structural motif provides an interesting 3D architecture with axial chirality, which further contributes to molecular complexity and specificity. Racemates and their separated atropisomers arrested the cell cycle, caused apoptosis, and affected microtubule organization in cancer cells in vitro at different intensities. Moreover, this phenomenon was also verified by the inhibition of endothelial cell migration. These results showed that (+)-atropisomers, especially 5n, exhibit a stronger effect and show promise as agents for cancer therapy.
- 8 July 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (34) , 6966-6980
Open AccessAtropisomeric 1-phenylbenzimidazoles affecting microtubule organization: influence of axial chirality
Benzimidazoles are frequently used in medicinal chemistry. Their anticancer effect is among the most prominent biological activities exhibited by this scaffold. Although numerous benzimidazole derivatives have been synthesized, possible atropisomerism of ortho-substituted 1-phenylbenzimidazoles has been largely overlooked. The aim of this research was to synthesize a small library of novel atropisomeric benzimidazole derivatives and explore their biological activity in various cancer and normal human cell lines. The new unique structural motif provides an interesting 3D architecture with axial chirality, which further contributes to molecular complexity and specificity. Racemates and their separated atropisomers arrested the cell cycle, caused apoptosis, and affected microtubule organization in cancer cells in vitro at different intensities. Moreover, this phenomenon was also verified by the inhibition of endothelial cell migration. These results showed that (+)-atropisomers, especially 5n, exhibit a stronger effect and show promise as agents for cancer therapy.
- 28 November 2018
- Published by American Chemical Society (ACS) in ACS Combinatorial Science
- Vol. 21 (1) , 1-5
Traceless Solid-Phase Synthesis of 1′H-Spiro[Pyrrolidine-3,2′-quinazolin]-2-ones and 1′H-Spiro[Piperidine-3,2′-quinazolin]-2-ones via Lactamization of 1,2-Dihydroquinazoline-2-carboxylates
We present the solid-phase synthesis of 1,2-dihydroquinazoline-2-carboxylate derivatives with a quaternary carbon in position 2 and their subsequent cyclization in solution into compounds with unique 3D architectures and pharmacological relevance – spiroquinazolines, namely, 1'H-spiro[pyrrolidine-3,2'-quinazolin]-2-ones and 1'H-spiro[piperidine-3,2'-quinazolin]-2-ones. Acyclic precursors were prepared from commercially available building blocks: protected amino acids (2,4-diaminobutyric acid and ornithine), 2-nitrobenzensulfonyl chlorides and α-bromoacetophenones. The crucial step of the synthesis was a base-mediated tandem reaction including C-arylation followed by cyclization into indazole oxides, and the formation of a 5-membered heterocycle was accomplished by ring expansion into quinazolines. These derivatives were cyclized into spiro compounds in solution after cleavage from the resin.
- 28 November 2018
- Published by American Chemical Society (ACS) in ACS Combinatorial Science
- Vol. 21 (1) , 1-5
Traceless Solid-Phase Synthesis of 1′H-Spiro[Pyrrolidine-3,2′-quinazolin]-2-ones and 1′H-Spiro[Piperidine-3,2′-quinazolin]-2-ones via Lactamization of 1,2-Dihydroquinazoline-2-carboxylates
We present the solid-phase synthesis of 1,2-dihydroquinazoline-2-carboxylate derivatives with a quaternary carbon in position 2 and their subsequent cyclization in solution into compounds with unique 3D architectures and pharmacological relevance – spiroquinazolines, namely, 1'H-spiro[pyrrolidine-3,2'-quinazolin]-2-ones and 1'H-spiro[piperidine-3,2'-quinazolin]-2-ones. Acyclic precursors were prepared from commercially available building blocks: protected amino acids (2,4-diaminobutyric acid and ornithine), 2-nitrobenzensulfonyl chlorides and α-bromoacetophenones. The crucial step of the synthesis was a base-mediated tandem reaction including C-arylation followed by cyclization into indazole oxides, and the formation of a 5-membered heterocycle was accomplished by ring expansion into quinazolines. These derivatives were cyclized into spiro compounds in solution after cleavage from the resin.